期刊文献+

丹蛭降糖胶囊对实验性糖尿病模型大鼠pref-1 mRNA表达的影响 被引量:5

Effects of Danzhijiangtang Capsule on Experimental Diabetes Animal Model in Rats of Pref-1mRNA Expression
原文传递
导出
摘要 目的:观察丹蛭降糖胶囊对小剂量链脲佐菌素(STZ)加高热量饮食诱导的实验性糖尿病模型大鼠脂肪组织前脂肪细胞因子-1(preadipocyte factor-1,pref-1)mRNA表达的影响。方法:雄性Wistar大鼠随机分为空白组、模型组、治疗组(马来酸罗格列酮组、丹蛭降糖胶囊组),空白组喂以基础饲料,模型组与治疗组注射小剂量STZ并喂以高热量饲料,提取大网膜脂肪组织总RNA,采用RT-PCR技术扩增pref-1基因片段,检测其表达水平。结果:丹蛭降糖胶囊能降低模型大鼠空腹胰岛素(Fins)含量,降低pref-1 mRNA表达,提高胰岛素敏感指数(ISI)。结论:丹蛭降糖胶囊对实验性糖尿病模型大鼠脂肪分化功能有显著改善作用,提示pref-1可能是其治疗2型糖尿病的一个作用靶点。 Objective:Experimental Study of DanzhiJiangtang Capsule(DJC)'s Effect on diabetic rats induced by low-dose streptozotocin(STZ) and high-energy diet.Preadipocyte factor-1 mRNA's expression was used for observation.Methods:Male Wistar rats were randomly divided into blank group,model group and treatment groups(rosiglitazone maleate group and DJC group),Normal diet was used to feed the blank group.Model group and treatment groups were injected with STZ and fed high-calorie feed.Total RNA was extracted from omental adipose tissue using RT-PCR amplified pref-1 gene fragment to detect the level of its expression.Results:DJC lowered the FIns content of model rats,reducing the expression of pref-1mRNA to improve the ISI.Conclusion:DJC has the effect of significant improvement for experimental diabetes on rat adipose differentiation.It indicates pref-1 may be a target for the treatment of typeⅡ diabetes.
出处 《中国实验方剂学杂志》 CAS 北大核心 2010年第3期64-67,共4页 Chinese Journal of Experimental Traditional Medical Formulae
基金 国家中医药管理局中医药科学技术研究专项(06-07LP22) 安徽省自然科学基金项目(070413130) 安徽省十一五科技攻关项目(08010302184)
关键词 糖尿病 脂肪分化:丹蛭降糖胶囊 前脂肪细胞因子-1 diabetes adipose differentiation DJC preadipocyte factor-1
  • 相关文献

参考文献8

二级参考文献14

  • 1鲁瑾,邹大进,郭品娥,卢斌.2型糖尿病患者血清C反应蛋白水平的研究[J].第二军医大学学报,2004,25(11):1268-1270. 被引量:10
  • 2李光伟,Step.,L.检测人群胰岛素敏感性的一项新指数[J].中华内科杂志,1993,32(10):656-660. 被引量:2125
  • 3方朝晖,王佑民,王开成,郭彦,刘玲,胡国平.丹蛭降糖胶囊对胰岛素抵抗大鼠PPAR-γ mRNA表达的影响[J].中国实验方剂学杂志,2006,12(4):36-39. 被引量:25
  • 4Shulman G I.Cellular mechanisms of insulin resistance[ J ].J Clin Invest,2000,106:171-176.
  • 5Cho YW,Yang DH,Oh DY,et al.Plasma tPA and PA I antigen concentrations in non-insulin dependent diabetic patients:implication for diabetes retinopathy.Diabetes Res Clin Pract,1994,22:123-128.
  • 6Bell WR.The fibrinolytic system in neoplasia.Semin Thromb Hemostas,1996,22:459-471.
  • 7Maiello M,Boeri D,Podesta F,et al.Increased expressin of tissue plasminogen activator and its inhibitor and reduced fibrinolytic potential of human endothelial cells cultured in elevated glucose.Diabetes,1992,41:1009.
  • 8Meigs JB,MittlemanMA.Nathan DM,et al.Hyperinsulinemia,hyperglycemia,and impaired hemostasis:the Framing ham.JAMA,2000,283:221.
  • 9Spiegelman BM.PPAR-gamma:adipogenic regulator and thiazolidinedione receptor.Diabetes,1998,47:507-514.
  • 10Brownlee M, The pathobiology of diabetic complication a unifying mechanisn[J], Diabetes, 2004, 53:6.

共引文献86

同被引文献59

引证文献5

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部